阵列生物传感器研究进展

简要介绍了阵列生物传感器的基本原理和分类。根据换能器的不同,评述了光学、电化学、质量型、磁致阻抗等阵列生物传感器的研究进展,并对目前阵列生物传感器研究中存在的问题进行了分析。     

阵列电化学生物传感器研究进展

阵列生物传感器技术作为一种高通量、快速、选择性高和集成化的分析技术,已在基因组学和蛋白质组学的研究和药物筛选、环境分析,食品分析,临床诊断等领域中得到广泛的应用.阵列生物传感器主要有阵列光学生物传感器和阵列电化学生物传感器.阵列电化学生物传感器是将生物分子识别物质如酶、抗原/抗体、DNA等固定在阵列电极上,以阵列中每根电极产生的电化学信号作为检测信号的电化学分析器件.阵列电化学生物传感器以灵敏度高、分析速度快、选择性好、易于微型化和集成化以及仪器价格低廉等特点受到了研究工作者的极大关注.本文简单介绍了阵列电化学生物传感器的原理和特点,重点评述了2005年以来阵列电化学生物传感器在单组份检测和多组份同时检测两方面的研究进展,简单讨论了阵列电化学生物传感器研究中存在的问题.     

DNA生物传感器研究进展

本根据作用机理不同将ＤＮＡ生物传感器分为ＤＮＡ光化学传感器,ＤＮＡ电化学传感器和压电晶体传感器,并就几种方面的研究进展进行了综述。     

荧光纳米生物传感器研究进展

荧光纳米生物传感器检测物质具有灵敏度高、响应迅速、抗干扰性强、无需参比电极等特点而被广泛地运用于生物传感技术领域。本文综述了荧光纳米生物传感器种类和特点,介绍了国内外近期在荧光纳米生物传感器及在生物检测方面的一些研究成果及进展,并作了分析比较。着重讨论了纳米粒子荧光生物传感器和光纤纳米荧光生物传感器的特性及其在生物分析中的应用。     

核酸生物传感器及其研究进展

核酸生物传感器在涉及分子生物学的研究领域具有重要意义.为适应分子生物学及其相关学科的发展需要,其研究正成为90年代生物传感技术研究热点.文章对核酸生物传感器的工作原理、分类、研究现状以及发展趋势作了较详细的介绍.     

CRISPR-Cas生物传感器研究进展

成簇规律间隔短回文序列(clustered regularly interspaced short palindromic repeats,CRISPR)系统是广泛存在于细菌中的一种特有的免疫防御机制,与特殊的Cas蛋白结合后能够有效的对外源的核酸分子进行特异性片段化,并进一步促进其降解。CRISPR-Cas系统具有独特的靶向性,为开发针对于核酸为底物的生物传感器提供了新的概念。越来越多的研究人员根据不同Cas蛋白的性质,建立了独特的逻辑系统对靶标物质进行准确识别,基于CRISPR技术的生物传感器也开拓了该技术在基因编辑以外领域的应用。介绍了CRISPR-Cas系统的起源、作用机制和科学分类,根据生物传感器的作用方式以及识别底物进行了分类,并对基于CRISPR-Cas系统的高效生物传感器的应用前景进行了展望。     

生物传感器的研究进展综述

生物传感器是一种对生物物质的敏感,并且将其浓度转换成电信号进行检测的仪器。生物传感器是一种由固定化的生物敏感材料作为识别酶、抗原和微生物等生物活性物质,并且能够和适当的理化换能器和信号放大设备构成的分析的系统或者是工具,具有接收器和转换器的功能。目前生物传感器在食品工业、环境监测和发酵工业以及医学等领域都有所应用,并且随着生物科学等成果的发展,已经有了飞速的发展。本文将对生物传感器的发展现状进行分析,并且简述其在各个领域的应用情况。     

微阵列电化学生物传感器研究进展

本文简要介绍了微阵列电化学生物传感器的基本原理和分类,评述了微阵列电化学生物传感器的研究进展。     

Biosensors for process control

Biosensors have been extensively studied during the last 20 years, and a myriad of laboratory biosensors have been developed. Improvements are required in biosensor design and performance before they become widely accepted in industrial process monitoring. However, as the biotechnology industry expands, biosensors may become more acceptable because, despite their limitations, they are the only devices capable of delivering the information required.     

Development of a RapidFire mass spectrometry assay and a fluorescence assay for the discovery of kynurenine aminotransferase II inhibitors to treat central nervous system disorders

Kynurenine aminotransferases convert kynurenine to kynurenic acid and play an important role in the tryptophan degradation pathway. Kynurenic acid levels in brain have been hypothesized to be linked to a number of central nervous system (CNS) disorders. Kynurenine aminotransferase II (KATII) has proven to be a key modulator of kynurenic acid levels in brain and, thus, is an attractive target to treat CNS diseases. A sensitive, high-throughput, label-free RapidFire mass spectrometry assay has been developed for human KATII. Unlike other assays, this method is directly applicable to KATII enzymes from different animal species, which allows us to select proper animal model(s) to evaluate human KATII inhibitors. We also established a coupled fluorescence assay for human KATII. The short assay time and kinetic capability of the fluorescence assay provide a useful tool for orthogonal inhibitor validation and mechanistic studies.     

Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer

The estrogen-related receptor-gamma (ERRgamma) is a constitutively active orphan receptor that belongs to the nuclear receptor superfamily and is most closely related to the estrogen receptors. Although its physiological ligand is unknown, ERRgamma has been shown to interact with synthetic estrogenic compounds such as 4-hydroxytamoxifen (4-OHT), tamoxifen, and diethylstilbestrol (DES). To assess how coregulator proteins interact with ERRgamma in response to ligand, an in vitro interaction methodology using time-resolved fluorescence resonance energy transfer (TR-FRET) was developed using glutathione S-transferase (GST)-tagged ERRgamma ligand-binding domain (LBD), a terbium-labeled anti-GST antibody, a fluorescein-labeled peptide containing sequences derived from coregulator proteins, and various ligands. An initial screen of these coregulator peptides bearing the coactivator LXXLL motif, the corepressor LXXI/HIXXXI/L motif, or other interaction motifs from natural coactivator sequences or random phage display peptides indicated that the peptides PGC1alpha, D22, and SRC1-4, known as class III coregulators, interacted most strongly with ERRgamma in the absence of ligand. Given its assay window and biological relevance in energy metabolism and obesity, further studies were conducted with PGC1alpha. Fluorescein-labeled PGC1alpha peptide was displaced from the ERRgamma LBD in the presence of increasing concentrations of 4-OHT and tamoxifen, but DES was less effective in PGC1alpha displacement. The statistical parameter Z' factor that measures the robustness of the assay was greater than 0.8 for displacement of PGC1alpha from ERRgamma LBD in the presence of saturating 4-OHT over an assay incubation time of 1-6 h, indicating an excellent assay. These findings also suggest that binding of 4-OHT, tamoxifen, or DES to ERRgamma results in differential affinity of coregulators for ERRgamma due to unique ligand-induced conformations.     

Optimization of antibody-conjugated magnetic nanoparticles for target preconcentration and immunoassays

Biosensors based on antibody recognition have a wide range of monitoring applications that apply to clinical, environmental, homeland security, and food problems. In an effort to improve the limit of detection of the Naval Research Laboratory (NRL) Array Biosensor, magnetic nanoparticles (MNPs) were designed and tested using a fluorescence-based array biosensor. The MNPs were coated with the fluorescently labeled protein, AlexaFluor647–chicken IgG (Alexa647–chick IgG). Antibody-labeled MNPs (Alexa647–chick–MNPs) were used to preconcentrate the target via magnetic separation and as the tracer to demonstrate binding to slides modified with anti-chicken IgG as a capture agent. A full optimization study of the antibody-modified MNPs and their use in the biosensor was performed. This investigation looked at the Alexa647–chick–MNP composition, MNP surface modifications, target preconcentration conditions, and the effect that magnetic extraction has on the Alexa647–chick–MNP binding with the array surface. The results demonstrate the impact of magnetic extraction using the MNPs labeled with fluorescent proteins both for target preconcentration and for subsequent integration into immunoassays performed under flow conditions for enhanced signal generation.